Note: The COVID-19 situation is continuously evolving; health care professionals can subscribe here to receive updates.
Click HealthFAX to see the most recent notices for health care professionals
Novel coronavirus can cause illness ranging from a very mild, cold-like illness to a severe lung infection. Some common symptoms are:
Some people such as the elderly and those who are immunocompromised may not develop a fever. For these individuals, the presence of new/worse cough or difficulty breathing may be enough to trigger further precautions.
Complications from the 2019 novel coronavirus can include serious conditions, like pneumonia or kidney failure, and in some cases, death.
Clinical Resources
Getting Ready for your COVID-19 Vaccine
COVID-19 Vaccine Consent Form
COVID-19 Fact Sheet
Moderna COVID-19 Vaccine Directive Template (Revised April 7, 2021)
Pfizer COVID-19 Vaccine Directive Template (Revised April 7, 2021)
Astra Zeneca COVID-19 Directive Template (Revised April 7, 2021)
Pregnancy and Breastfeeding Decision-Making Tool (March 8,2021) Provincial Council for Maternal Child Health
Guidance for Obstetrics and Perinatal Care (Society of Obstetricians and Gynaecologists of Canada)
COVID-19 Vaccine - Relevant Information and Planning Resources
NEW: AstraZeneca Vaccine for Primary Care Providers
COVID-19 vaccine continues to be available in very limited supply, and as such every possible precaution must be taken to ensure that vaccine is administered as efficiently and safely as possible to those eligible in accordance with the provincial priority framework, and any wastage of vaccine is minimized. Primary care providers who have public health inspected vaccine fridges and routinely carry publicly funded vaccines in their practices are able to access a supply of AstraZeneca COVID-19 vaccine to store, handle and administer. In order to do so, providers will be required to:
If you are interested in accessing AstraZeneca COVID-19 vaccine to store, handle and administer in your practice, please email [email protected] indicating your interest and someone will connect with you to review next steps.
Other Web Links:
COVID-19 Vaccine Information - Public Health Agency of Canada
COVID-19 Vaccines for Ontario - Ontario Ministry of Health
Pfizer-BioNTech COVID-19 Vaccine 9 (tozinameran) Product Monograph
Moderna COVID-19 Vaccine Product Monograph
NACI Recommendations on the use of COVID-19 vaccine(s)
NACI Guidance on the prioritization of initial doses of COVID-19 vaccine(s)
SMDHU COVID-19 Variant of Concern (VOC) Strategy
Assessment of Exposure Risk: COVID-19 Variants of Concern
Ministry of Health-COVID-19 Variant of Concern: Case, Contact and Outbreak Management Interim Guidance
Variant of Concern (VOC) Surveillance Testing
Newest Guidelines/Documents
Accessing Personal Protective Equipment (PPE): If unable to access PPE through the usual suppliers see the Ontario Health: Quick Reference - PPE and Critical Supplies Escalation Process for assistance in requesting from the provincial supply.
Increased frequency of cleaning high-touch surfaces is significant in controlling the spread of microorganisms during a respiratory infection outbreak. Environmental cleaning products registered in Canada with a Drug Identification Number (DIN) and labelled as a broad-spectrum virucide are sufficient for 2019-nCoV. All surfaces, especially those that are horizontal and frequently touched, should be cleaned at least twice daily and when soiled. The healthcare organization's terminal cleaning protocol for cleaning of the patient's room after discharge, transfer, or discontinuation of contact and droplet precautions should be followed.
Public Settings
Case Management
Reporting
Testing
Specimen Collection Information
Other Links
